Are you going to substantiate your claims with any evidence? How do you figure revenue has increased very little? Why is your focus on revenue over NPAT/EPS?
FY21 FY22 FY23 1 Revenue 235.7 310 491.8 2 NPAT 7.131 7.76 19.2 3 EPS 3.1 3.2 7.91 4 ROE 27.50% 25% 42%
This is a company where management owns over 32%, has compounded 34% annually, making several acquisitions along the way,
ALL while being fully self funded since 2010.
At $1.35 the trailing PE is 17.
If you don't believe this company will be able to grow EPS in FY24 & beyond then maybe you would consider it fully priced.
Based on managements historic performance & the future prospects of the company, I am betting against you.
Interesting company, page-45
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DUR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.015(1.35%) |
Mkt cap ! $279.4M | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.13 | $1.10 | $315.8K | 284.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2388 | $1.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 15110 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| DUR (ASX) Chart |